Results 221 to 230 of about 85,956 (353)

Germ cell and other tumors in individuals with differences in sex development

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Approximately one in 3500 to one in 5100 live‐born infants have atypical external genital development, known as differences in sex development (DSD). In 2005, an expert consensus conference thoroughly reviewed aspects of health care for individuals with DSD.
Selma Feldman Witchel, Miguel Reyes‐Múgica   +1 more
wiley   +1 more source

Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism. [PDF]

, 1996
Y. Takahashi, Kanshi Minamitani, Yasuyuki Kobayashi, Masahiro Minagawa, Toshiyuki Yasuda, H Niimi   +5 more
openalex   +1 more source

Understanding women's sex hormone physiology—A priority in diabetes care

Diabetic Medicine, EarlyView.
Céline Isabelle Laesser, Bettina Weber, David Studer, Reem Jalal Alshareef, Lia Bally   +4 more
wiley   +1 more source

Update and new advances in fertility preservation and cancer

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Adolescents and young adults with a cancer diagnosis face unique challenges during treatment and into survivorship related to fertility and family building. This review provides an updated overview of the impact of cancer and its associated treatments, including novel treatments in male and female fertility.
Gwendolyn P. Quinn, Michelle Bayefsky, Brooke Cherven, Lauren V. Ghazal, Kara N. Goldman, Nina Francis Levin, Leena Nahata, Bobby Najari, Sameer Thakker, Daniel R. Greenberg, Joshua A. Halpern, Susan T. Vadaparampil   +11 more
wiley   +1 more source

Prolonged post-androgen abuse hypogonadism: potential mechanisms and a proposed standardized diagnosis. [PDF]

Front Endocrinol (Lausanne)
van Os J, Smit DL, Bond P, de Ronde W.
europepmc   +1 more source

Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism. [PDF]

, 1996
Metin Özata, Metin Yıldırımkaya, M Bulur, Keziban Naz Yılmaz, Erol Bolu, Ahmet Çorakçı, M. Ali Gündoğan   +6 more
openalex   +1 more source

Australian and New Zealand joint society consensus statement on genetic testing for monogenic diabetes in adults

Medical Journal of Australia, EarlyView.
Abstract Introduction Monogenic diabetes accounts for 2–5% of diabetes. Although its identification has substantial therapeutic implications, more than 80% of affected individuals are undiagnosed or misdiagnosed as having type 1 or 2 diabetes. This consensus statement reviews genetic testing for monogenic diabetes in adults and provides evidence‐based ...
Sunita MC De Sousa, Timothy ME Davis, James Harraway, Mark Greenslade, Kathy HC Wu, Ryan G Paul, Juliet Taylor, Aleena S Ali, Elif I Ekinci, Rinki Murphy, Jerry R Greenfield   +10 more
wiley   +1 more source

Certain Metabolic Syndrome Component Combinations are Linked to Increased Risk of Hypogonadism in Taiwanese Men. [PDF]

Diabetes Metab Syndr Obes
Hong YH, Hung KC, Lin CL, Hung CL, Tu SK, Yang DH, Liao CC.   +6 more
europepmc   +1 more source

Profound Hypogonadism Has Significant Negative Effects on Calcium Balance in Males: A Calcium Kinetic Study [PDF]

, 1999
Nelly Mauras, Valerie Y. Hayes, Nancy E. Vieira, Alfred L. Yergey, Kimberly O’Brien   +4 more
openalex   +1 more source

Synthesis and In Vitro Metabolic Profiling of the Selective Androgen Receptor Modulator (SARM) LY305

Rapid Communications in Mass Spectrometry, Volume 39, Issue 22, 30 November 2025.
ABSTRACT Rationale 2‐Chloro‐4‐[[(1R,2R)‐2‐hydroxy‐2‐methyl‐cyclopentyl]amino]‐3‐methyl‐benzonitrile (LY305) is a transdermal selective androgen receptor modulator (SARM) that has been under development as a potential therapeutic for conditions involving muscle wasting, osteoporosis, or hypogonadism.
Giorgi Kobidze, Tristan Möller, Hui‐Chung Wen, Francesco Paolo Busardò, Mario Thevis   +4 more
wiley   +1 more source